Australia's Alterity Therapeutics to start phase 2 trial of neuro drug in UK

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerativ...

April 28, 2022 | Thursday | News
Anteris Technologies partners with Yale University

Australia's Anteris Technologies has announced its research partnership with Yale University and the Yale Cardiova...

April 28, 2022 | Thursday | News
Singapore's HealthBeats raises $3M in seed funding

HealthBeats, a Singapore-based healthtech startup with end-to-end remote vitals monitoring solution, has announced the c...

April 28, 2022 | Thursday | News
China's Antengene looks to start phase I trial in Australia

China's Antengene Corporation, a leading innovative, commercial-stage global biopharmaceutical company dedicated to disc...

April 27, 2022 | Wednesday | News
Australia's DetectedX and GE Healthcare announce mammography education partnership

Fostering global excellence in diagnostic accuracy, Australia-based DetectedX and GE Healthcare have entered into an edu...

April 26, 2022 | Tuesday | News
Australia provides grant worth $4 M for stroke and kidney disease research

More than $4 million has been awarded to two projects at The George Institute for Global Health at UNSW Sydney, Australi...

April 25, 2022 | Monday | News
Australia-based SpeeDx expands COVID-19 diagnostics to include self-collected samples

Australia's SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has added saliva to the list of ...

April 22, 2022 | Friday | News
Australian Contract Research Organisation (CRO) Avance Clinical leads in APAC

Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has bee...

April 20, 2022 | Wednesday | News
Australia develops skin microbiopsy device to change skin cancer diagnosis

A skin microbiopsy device developed by researchers at The University of Queensland (UQ) in Australia, that takes tissue ...

April 19, 2022 | Tuesday | News
Australia explores risk reduction of stroke and heart problems after surgery

Researchers from the University of Sydney and Westmead Hospital in Australia have been awarded $1.8 million to advance r...

April 18, 2022 | Monday | News
Australia's Telix starts US trial

Australia's Telix Pharmaceuticals has announced first commercial doses of its prostate cancer imaging agent, Illuccix&re...

April 18, 2022 | Monday | News
Stroke cuts life expectancy by one third: Australian study

Almost two thirds of acute stroke patients fail to survive more than a decade and have high risk of recurrence, promptin...

April 15, 2022 | Friday | News
FDA grants Fast Track designation for Paradigm Biopharmaceuticals Phase III Osteoarthritis Program

Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...

April 14, 2022 | Thursday | News
Australia's ResApp and Pfizer enter into R&D license agreement

Australia's ResApp Health Limited has entered into a binding scheme implementation deed with Pfizer Australia Holdings P...

April 13, 2022 | Wednesday | News
Australia develops wireless neuro-stimulator to revolutionise patient care

Many neurological disorders like Parkinson’s, chronic depression and other psychiatric conditions could be managed...

April 12, 2022 | Tuesday | News
Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer

Australian and US MedTech startup Nutromics (Nutromics or the Company), a global leader in DNA-based biosensors, announc...

April 12, 2022 | Tuesday | News
Australia-based Telix Pharmaceuticals inks oncology deal with Eli Lilly

Australia's Telix Pharmaceuticals has entered into a licence agreement with Eli Lilly and Company under which Telix is g...

April 11, 2022 | Monday | News
Medriva announces availability of new COVID-19 Rapid Antigen Test kits in Australia

Medriva, a leading global manufacturer of COVID-19 testing and vaccination products, has announced the Australian a...

April 8, 2022 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls